Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Risedronate Market Status and Forecast (2016-2027)
  • 1.3.2 Global Risedronate Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Risedronate Supply by Company

• 2.1 Global Risedronate Sales Volume by Company
• 2.2 Global Risedronate Sales Value by Company
• 2.3 Global Risedronate Price by Company
• 2.4 Risedronate Production Location and Sales Area of Main Manufacturers
• 2.5 Trend of Concentration Rate

3 Global and Regional Risedronate Market Status by Category

• 3.1 Risedronate Category Introduction
  • 3.1.1 5 mg Tablets
  • 3.1.2 35 mg Tablets
  • 3.1.3 75 mg Tablets
  • 3.1.4 150 mg Tablets
• 3.2 Global Risedronate Market by Category
  • 3.2.1 Global Risedronate Sales Volume by Category (2016-2021)
  • 3.2.2 Global Risedronate Sales Value by Category (2016-2021)
  • 3.2.3 Global Risedronate Price by Category (2016-2021)
• 3.3 North America: by Category
• 3.4 Europe: by Category
• 3.5 Asia Pacific: by Category
• 3.6 Central & South America: by Category
• 3.7 Middle East & Africa: by Category

4 Global and Regional Risedronate Market Status by End User/Segment

• 4.1 Risedronate Segment by End User/Segment
  • 4.1.1 Postmenopausal Osteoporosis
  • 4.1.2 Men with Osteoporosis
• 4.2 Global Risedronate Market by End User/Segment
  • 4.2.1 Global Risedronate Sales Volume by End User/Segment (2016-2021)
  • 4.2.2 Global Risedronate Sales Value by End User/Segment (2016-2021)
  • 4.2.3 Global Risedronate Price by End User/Segment (2016-2021)
• 4.3 North America: by End User/Segment
• 4.4 Europe: by End User/Segment
• 4.5 Asia Pacific: by End User/Segment
• 4.6 Central & South America: by End User/Segment
• 4.7 Middle East & Africa: by End User/Segment

5 Global Risedronate Market Status by Region

• 5.1 Global Risedronate Market by Region
  • 5.1.1 Global Risedronate Sales Volume by Region
  • 5.1.2 Global Risedronate Sales Value by Region
• 5.2 North America Risedronate Market Status
• 5.3 Europe Risedronate Market Status
• 5.4 Asia Pacific Risedronate Market Status
• 5.5 Central & South America Risedronate Market Status
• 5.6 Middle East & Africa Risedronate Market Status

6 North America Risedronate Market Status

• 6.1 North America Risedronate Market by Country
  • 6.1.1 North America Risedronate Sales Volume by Country (2016-2021)
  • 6.1.2 North America Risedronate Sales Value by Country (2016-2021)
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Risedronate Market Status

• 7.1 Europe Risedronate Market by Country
  • 7.1.1 Europe Risedronate Sales Volume by Country (2016-2021)
  • 7.1.2 Europe Risedronate Sales Value by Country (2016-2021)
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Risedronate Market Status

• 8.1 Asia Pacific Risedronate Market by Country
  • 8.1.1 Asia Pacific Risedronate Sales Volume by Country (2016-2021)
  • 8.1.2 Asia Pacific Risedronate Sales Value by Country (2016-2021)
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Risedronate Market Status

• 9.1 Central & South America Risedronate Market by Country
  • 9.1.1 Central & South America Risedronate Sales Volume by Country (2016-2021)
  • 9.1.2 Central & South America Risedronate Sales Value by Country (2016-2021)
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Risedronate Market Status

• 10.1 Middle East & Africa Risedronate Market by Country
  • 10.1.1 Middle East & Africa Risedronate Sales Volume by Country (2016-2021)
  • 10.1.2 Middle East & Africa Risedronate Sales Value by Country (2016-2021)
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Supply Chain and Manufacturing Cost Analysis

• 11.1 Supply Chain Analysis
• 11.2 Production Process Chart Analysis
• 11.3 Raw Materials and Key Suppliers Analysis
  • 11.3.1 Raw Materials Introduction
  • 11.3.2 Raw Materials Key Suppliers List
• 11.4 Risedronate Manufacturing Cost Analysis
• 11.5 Risedronate Sales Channel and Distributors Analysis
  • 11.5.1 Risedronate Sales Channel
  • 11.5.2 Risedronate Distributors
• 11.6 Risedronate Downstream Major Buyers

12 Global Risedronate Market Forecast by Category and by End User/Segment

• 12.1 Global Risedronate Sales Volume and Sales Value Forecast (2022-2027)
• 12.2 Global Risedronate Forecast by Category
  • 12.2.1 Global Risedronate Sales Volume Forecast by Category
  • 12.2.2 Global Risedronate Sales Value Forecast by Category
  • 12.2.3 Global Risedronate Price Forecast by Category
• 12.3 Global Risedronate Forecast by End User/Segment
  • 12.3.1 Global Risedronate Sales Volume Forecast by End User/Segment
  • 12.3.2 Global Risedronate Sales Value Forecast by End User/Segment
  • 12.3.3 Global Risedronate Price Forecast by End User/Segment

13 Global Risedronate Market Forecast by Region/Country

• 13.1 Global Risedronate Market Forecast by Region (2022-2027)
  • 13.1.1 Global Risedronate Sales Volume Forecast by Region (2022-2027)
  • 13.1.2 Global Risedronate Sales Value Forecast by Region (2022-2027)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 Teva
  • 14.1.1 Company Information
  • 14.1.2 Risedronate Product Introduction
  • 14.1.3 Teva Risedronate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.1.4 SWOT Analysis
• 14.2 Tecoland
  • 14.2.1 Company Information
  • 14.2.2 Risedronate Product Introduction
  • 14.2.3 Tecoland Risedronate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.2.4 SWOT Analysis
• 14.3 Taj Pharmaceuticals
  • 14.3.1 Company Information
  • 14.3.2 Risedronate Product Introduction
  • 14.3.3 Taj Pharmaceuticals Risedronate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.3.4 SWOT Analysis
• 14.4 Sanofi
  • 14.4.1 Company Information
  • 14.4.2 Risedronate Product Introduction
  • 14.4.3 Sanofi Risedronate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.4.4 SWOT Analysis
• 14.5 Novartis
  • 14.5.1 Company Information
  • 14.5.2 Risedronate Product Introduction
  • 14.5.3 Novartis Risedronate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.5.4 SWOT Analysis
• 14.6 Mylan
  • 14.6.1 Company Information
  • 14.6.2 Risedronate Product Introduction
  • 14.6.3 Mylan Risedronate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.6.4 SWOT Analysis
• 14.7 Merck
  • 14.7.1 Company Information
  • 14.7.2 Risedronate Product Introduction
  • 14.7.3 Merck Risedronate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.7.4 SWOT Analysis
• 14.8 Apotex
  • 14.8.1 Company Information
  • 14.8.2 Risedronate Product Introduction
  • 14.8.3 Apotex Risedronate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.8.4 SWOT Analysis
• 14.9 Amgen
  • 14.9.1 Company Information
  • 14.9.2 Risedronate Product Introduction
  • 14.9.3 Amgen Risedronate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.9.4 SWOT Analysis
• 14.10 Abbott
  • 14.10.1 Company Information
  • 14.10.2 Risedronate Product Introduction
  • 14.10.3 Abbott Risedronate Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
  • 14.10.4 SWOT Analysis

15 Conclusion

16 Methodology

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Risedronate market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Risedronate market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
5 mg Tablets
35 mg Tablets
75 mg Tablets
150 mg Tablets

Segmented by End User/Segment
Postmenopausal Osteoporosis
Men with Osteoporosis

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Teva
Tecoland
Taj Pharmaceuticals
Sanofi
Novartis
Mylan
Merck
Apotex
Amgen
Abbott